Loudon William, Kardosh Michael, Cros Florent, Katznelson Be'eri, Shtein Aviv, Fedotenko Katerina, Castel Didi, Palmer Olin J, Kiselyov Alexander
Department of Neurosurgery, Children's Hospital Orange County, Orange, California, United States.
Department of Research and Development, Bionaut Labs Inc., Culver City, Israel.
Surg Neurol Int. 2025 May 2;16:157. doi: 10.25259/SNI_841_2024. eCollection 2025.
To expand surgical options for safe, minimally invasive microsurgical procedures or targeted delivery of diverse therapeutics, a novel untethered micro-robotic platform is presented. This technology enables precision travel to predetermined central nervous system (CNS) parenchymal and complex cerebrospinal fluid pathway targets.
Utilizing an ovine model, gross pathological and microscopic histopathological brain tissue reactions to the navigation of this micro-robot were compared to inserting standard neurosurgical catheters, routed from an occipital burr hole to the frontal lobe and then returning. Descriptions of the evolving tissue responses were documented at 24 h, 2, 12, and 26 weeks following the procedures.
No deaths or surgical complications occurred in either group. No neurological or behavioral differences were identified between the groups. No significant differences in gross or microscopic tissue pathology were identified when comparing the channels created by the micro-robot to the catheter control group.
These findings support the equivalence of tissue responses to this micro-robot navigation compared to catheter insertion as a preliminary surrogate for addressing the safety and accuracy of this novel platform. This platform may set a new standard for safe, anatomically precise, and minimally invasive therapeutic procedures. The described approach offers untethered navigation, capable of traversing CNS tissues in controlled, complex, curvilinear trajectories. Preliminary results utilizing this micro-robotic capacity to deliver diverse therapeutic payloads are discussed. Novel applications designed to address CNS pathologies, including neurodegenerative diseases, epilepsy, neuro-oncology, and functional and microsurgical procedures, are proposed.
为了扩大安全的微创显微外科手术或多种治疗方法靶向递送的手术选择,提出了一种新型的无系留微型机器人平台。该技术能够精确到达预定的中枢神经系统(CNS)实质和复杂的脑脊液通路靶点。
利用绵羊模型,将该微型机器人导航引起的大体病理和微观组织病理学脑组织反应与插入标准神经外科导管(从枕骨钻孔路由到额叶然后返回)的反应进行比较。在手术后24小时、2周、12周和26周记录不断演变的组织反应描述。
两组均未发生死亡或手术并发症。两组之间未发现神经或行为差异。将微型机器人创建的通道与导管对照组进行比较时,在大体或微观组织病理学上未发现显著差异。
这些发现支持与导管插入相比,该微型机器人导航的组织反应具有等效性,可作为解决这一新型平台安全性和准确性的初步替代指标。该平台可能为安全、解剖学精确和微创治疗程序设定新的标准。所描述的方法提供了无系留导航,能够以可控的、复杂的、曲线轨迹穿越中枢神经系统组织。讨论了利用这种微型机器人能力递送多种治疗载荷的初步结果。提出了旨在解决中枢神经系统疾病(包括神经退行性疾病、癫痫、神经肿瘤以及功能和显微外科手术)的新应用。